Nanoformulation of PROteolysis Targeting Chimera TArgeting ‘Undruggable’ C-Myc for The Treatment of...
Nanoformulation of PROteolysis Targeting Chimera TArgeting ‘Undruggable’ C-Myc for The Treatment of Pancreatic Cancer
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Aim: To explore the anticancer activity of a novel BRD4 protein degrader ARV-825 (ARV) and its nanoformulation development (ARV-NP) for treatment of pancreatic cancer. Materials & methods: ARV-NP were prepared using nanoprecipitation method and characterized for their physicochemical properties and various anticancer cell culture assays. Results: A...
Alternative Titles
Full title
Nanoformulation of PROteolysis Targeting Chimera TArgeting ‘Undruggable’ C-Myc for The Treatment of Pancreatic Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2426537301
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2426537301
Other Identifiers
ISSN
1743-5889
E-ISSN
1748-6963
DOI
10.2217/nnm-2020-0156
